[1] Wrzosek M, Łukaszkiewicz J, Wrzosek M, et al. Vitamin D and the central nervous system[J]. Pharmacol Rep, 2013, 65(2): 271–278. doi:  10.1016/S1734-1140(13)71003-X
[2] Borowicz KK, Morawska M, Furmanek-Karwowska K, et al. Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock[J]. Eur J Pharmacol, 2007, 573(1–3): 111–115. doi:  10.1016/j.ejphar.2007.07.002
[3] Miratashi Yazdi SA, Abbasi M, Miratashi Yazdi SM. Epilepsy and vitamin D: a comprehensive review of current knowledge[J]. Rev Neurosci, 2017, 28(2): 185–201. doi:  10.1515/revneuro-2016-0044
[4] Procopio M, Marriott PK, Davies RJE. Seasonality of birth in epilepsy: a southern Hemisphere study[J]. Seizure, 2006, 15(1): 17–21. doi:  10.1016/j.seizure.2005.10.001
[5] Shellhaas RA, Barks AK, Joshi SM. Prevalence and risk factors for vitamin D insufficiency among children with epilepsy[J]. Pediatr Neurol, 2010, 42(6): 422–426. doi:  10.1016/j.pediatrneurol.2010.03.004
[6] Bergqvist AGC, Schall JI, Stallings VA. Vitamin D status in children with intractable epilepsy, and impact of the ketogenic diet[J]. Epilepsia, 2007, 48(1): 66–71. doi:  10.1111/j.1528-1167.2006.00803.x
[7] Turan MI, Cayir A, Ozden O, et al. An examination of the mutual effects of valproic acid, carbamazepine, and phenobarbital on 25-hydroxyvitamin D levels and thyroid function tests[J]. Neuropediatrics, 2014, 45(1): 16–21. doi:  10.1055/s-0033-1349226
[8] Verrotti A, Agostinelli S, Coppola G, et al. A 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy[J]. Eur J Neurol, 2010, 17(2): 232–237. doi:  10.1111/j.1468-1331.2009.02773.x
[9] Xu ZJ, Jing X, Li GZ, et al. Valproate decreases vitamin D levels in pediatric patients with epilepsy[J]. Seizure, 2019, 71: 60–65. doi:  10.1016/j.seizure.2019.06.009
[10] Fong CY, Kong AN, Poh BK, et al. Vitamin D deficiency and its risk factors in Malaysian children with epilepsy[J]. Epilepsia, 2016, 57(8): 1271–1279. doi:  10.1111/epi.13443
[11] Geng XJ, Kang X, Wong PCM. Autism spectrum disorder risk prediction: A systematic review of behavioral and neural investigations[J]. Prog Mol Biol Transl Sci, 2020, 173: 91–137. doi:  10.1016/bs.pmbts.2020.04.015
[12] Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline[J]. J Clin Endocrinol Metab, 2011, 96(7): 1911–1930. doi:  10.1210/jc.2011-0385
[13] Guo HL, Jing X, Sun JY, et al. Valproic acid and the liver injury in patients with epilepsy: an update[J]. Curr Pharm Des, 2019, 25(3): 343–351. doi:  10.2174/1381612825666190329145428
[14] Borusiak P, Langer T, Heruth M, et al. Antiepileptic drugs and bone metabolism in children: data from 128 patients[J]. J Child Neurol, 2013, 28(2): 176–183. doi:  10.1177/0883073812443005
[15] Kim SH, Lee JW, Choi KG, et al. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy[J]. Epilepsy Behav, 2007, 10(2): 291–295. doi:  10.1016/j.yebeh.2006.11.007
[16] Durá-Travé T, Gallinas-Victoriano F, Malumbres-Chacón M, et al. Vitamin D deficiency in children with epilepsy taking valproate and levetiracetam as monotherapy[J]. Epilepsy Res, 2018, 139: 80–84. doi:  10.1016/j.eplepsyres.2017.11.013
[17] Chaudhuri JR, Mridula KR, Rathnakishore C, et al. Association of 25-Hydroxyvitamin D Deficiency in Pediatric Epileptic Patients[J]. Iran J Child Neurol, 2017, 11(2): 48–56. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493830/
[18] Poh BK, Ng BK, Siti Haslinda MD, et al. Nutritional status and dietary intakes of children aged 6 months to 12 years: findings of the Nutrition Survey of Malaysian Children (SEANUTS Malaysia)[J]. Br J Nutr, 2013, 110(S3): S21–S35. doi:  10.1017/S0007114513002092
[19] Lee SH, Yu J. Risk factors of vitamin D deficiency in children with epilepsy taking anticonvulsants at initial and during follow-up[J]. Ann Pediatr Endocrinol Metab, 2015, 20(4): 198–205. doi:  10.6065/apem.2015.20.4.198
[20] Yetley EA. Assessing the vitamin D status of the US population[J]. Am J Clin Nutr, 2008, 88(2): 558S–564S. doi:  10.1093/ajcn/88.2.558S
[21] Nettekoven S, Ströhle A, Trunz B, et al. Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy[J]. Eur J Pediatr, 2008, 167(12): 1369–1377. doi:  10.1007/s00431-008-0672-7
[22] Lee YJ, Park KM, Kim YM, et al. Longitudinal change of vitamin D status in children with epilepsy on antiepileptic drugs: prevalence and risk factors[J]. Pediatr Neurol, 2015, 52(2): 153–159. doi:  10.1016/j.pediatrneurol.2014.10.008
[23] Yildiz EP, Poyrazoglu Ş, Bektas G, et al. Potential risk factors for vitamin D levels in medium- and long-term use of antiepileptic drugs in childhood[J]. Acta Neurol Belg, 2017, 117(2): 447–453. doi:  10.1007/s13760-017-0775-x
[24] Wimalawansa SJ. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome[J]. J Steroid Biochem Mol Biol, 2018, 175: 177–189. doi:  10.1016/j.jsbmb.2016.09.017
[25] Romoli M, Mazzocchetti P, D'Alonzo R, et al. Valproic acid and epilepsy: from molecular mechanisms to clinical evidences[J]. Curr Neuropharmacol, 2019, 17(10): 926–946. doi:  10.2174/1570159X17666181227165722
[26] Thiel R. Might calcium disorders cause or contribute to myoclonic seizures in epileptics?[J]. Med Hypotheses, 2006, 66(5): 969–974. doi:  10.1016/j.mehy.2005.11.018
[27] McGrath JJ, Féron FP, Burne THJ, et al. Vitamin D3—implications for brain development[J]. J Steroid Biochem Mol Biol, 2004, 89–90: 557–560. doi:  10.1016/j.jsbmb.2004.03.070
[28] Bivona G, Agnello L, Bellia C, et al. Non-skeletal activities of vitamin D: from physiology to brain pathology[J]. Medicina (Kaunas), 2019, 55(7): 341. doi:  10.3390/medicina55070341
[29] Grecksch G, Rüthrich H, Höllt V, et al. Transient prenatal vitamin D deficiency is associated with changes of synaptic plasticity in the dentate gyrus in adult rats[J]. Psychoneuroendocrinology, 2009, 34(Suppl 1): S258–S264. doi:  10.1016/j.psyneuen.2009.07.004